サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1247436

網膜インプラントの世界市場-2023-2030

Global Retinal Implants Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
網膜インプラントの世界市場-2023-2030
出版日: 2023年03月28日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

網膜インプラントの世界市場規模は、2022年に5,978万米ドルとなり、2030年には1億1,817万米ドルに達すると予測され、予測期間（2023年～2030年）に9.1%のCAGRで成長するとされています。

バイオニックアイの一種である網膜プロテーゼまたはインプラントは、移植可能な電子デバイスであり、加齢黄斑変性や網膜色素変性など、視覚野や視神経が影響を受けていない重大な網膜障害を持つ人々の目に、視覚感覚を刺激するように設計されています。

市場力学

網膜インプラントの世界市場を牽引する主な要因は、適切な治療を必要とする眼疾患の増加による高度な機器に対する需要の高まり、啓発活動の急増、新規製品の発売につながる技術の進歩です。

網膜損傷の増加や老年人口の増加は、市場の成長を促進すると予想されます。

網膜インプラント市場は、インプラントの需要増加、技術の進歩の高まり、老人人口の増加、研究開発投資の急増、眼疾患の増加、新興国市場の医療インフラの改善とともに最新技術を用いた新規製品の改善によって牽引されています。

網膜インプラントは、眼の視覚感覚を刺激するために広く使用されています。これらのデバイスの採用が増加しているため、政府の取り組みや資金が増加しています。これらの資金は、PRIMA、IRIS V2、Argus IIなど、網膜色素変性症の治療用としてより開発された製品の生産に貢献します。網膜インプラントの市場は、網膜障害に苦しむ人々の増加により、世界中で拡大しています。さらに、主要企業が技術的に高度な製品を提供していることも、市場の成長に重要な役割を果たすと期待されています。

これらの網膜インプラントに関連する様々な新規製品の発売、調査研究、啓発活動の高まりは、市場の成長に寄与しています。例えば、2022年1月31日、Bionic Vision Technologies（BVT）は、世界初のオーストラリアのBionic Eye Systemが米国食品医薬品局から画期的なデバイス指定を受けたことについて発表しました。この画期的な技術は、遺伝的疾患である網膜色素変性症（RP）により視力を失った人々に機能的な視力を提供します。

網膜疾患に伴う治療費の高騰は、市場の成長を妨げると予想されます。

しかし、網膜インプラントに関連する償還政策が不透明であることが、市場成長を阻害する主な要因となっています。この不確実性により、臨床医だけでなく患者もこれらのデバイスの採用を躊躇しています。

また、網膜障害に関連する治療費の高さも、網膜インプラント市場の成長を阻害する要因となっています。Argus IIのような高度なインプラントは、約115,000ドルから150,000ドルの費用がかかります。低・中所得国に住む人々は、このような高価な製品を購入することができないのです。

COVID-19影響度分析

パンデミックは、世界の財務上の期待、事業運営、危機対応戦略にマイナスの影響を与えました。COVID-19の発生は、ヘルスケア業界に深刻な影響を与えています。網膜インプラント市場は、COVIDにより莫大な損失を被っています。主要メーカーは様々な研究や臨床試験を開始しました。

様々なイニシアチブ、製品の発売、コラボレーション、合併が世界中で起こっており、市場の成長を後押ししています。網膜に関連する眼疾患とその治療に関する国民の意識の高まりも、今後の市場を牽引していくことでしょう。

目次

第1章 調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲について

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 増加する網膜の損傷
      • 老年人口が増加する
    • 抑制要因
      • 治療費の高騰
    • 機会
    • 影響度分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格アナリシス

第6章 COVID-19の分析

  • 市場におけるCOVID-19の分析
    • COVID-19の市場シナリオの前に
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以降または将来シナリオ
  • COVID-19の中での価格・ダイナミクス
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • 結論

第7章 製品タイプ別

  • Argus II Retinal Prosthesis System
  • レティナインプラントαIMS
  • 光電網膜インプラント（PRIMA）
  • EPI-RET3
  • インテリジェント・レティナル・インプラント・システム（IRIS V2）
  • 脈絡膜上網膜プロテーゼ
  • 網膜下プロテーゼ

第8章 インプラントタイプ別

  • エピレチナル
  • サブレティナル
  • 脈絡膜上（Suprachoidal

第9章 アプリケーション別

  • 網膜色素変性症
  • 加齢黄斑変性症（Age-Related Macular Degeneration
  • 糖尿病性眼疾患
  • 網膜剥離

第10章 エンドユーザー別

  • 病院
  • 外来手術センター
  • アイケアセンター

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • U.K.
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な発展と戦略
  • 企業シェア分析
  • 製品ベンチマーキング
  • 注目の主要企業一覧

第13章 企業プロファイル

  • Bionic Vision Technologies
    • 会社概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Vivani Medical, Inc.
  • Samsara Vision Inc.
  • Visus Technology Inc.
  • Pixium Vision
  • Nano Retina
  • Labtician Ophthalmics, Inc.
  • VisionCare, Inc.
  • Cicor Management AG
  • Second Sight Medical Products Inc.

第14章 網膜インプラントの世界市場-DataM

目次
Product Code: MD1303

Market Overview

The global retinal implants market size was valued at US$ 59.78 million in 2022 and is estimated to reach US$ 118.17 million by 2030, growing at a CAGR of 9.1% during the forecast period (2023-2030).

Retinal prostheses or implants, a kind of bionic eye, are electronic devices which are implantable and are designed to stimulate vision sensation in the eyes of people with significant retinal disorders such as age-related macular degeneration or retinitis pigmentosa, where the visual cortex or optic nerve are unaffected.

Market Dynamics

The major factors driving the global retinal implants market are the rising demand for advanced devices owing to increasing incidences of ocular disorders requiring proper treatment, surging awareness initiatives, advancements in technologies leading to novel product launches.

The increasing number of retinal damages and rising geriatric populations are expected to drive the market's growth.

The retinal implants market is driven by increasing demand of implants, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ocular diseases and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The retinal implants are used widely for stimulating the eye vision sensation. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce more developed products such as PRIMA, IRIS V2 and Argus II for treating retinal pigmentosa. The market for these retinal implants is increasing worldwide due to the enhanced number of people suffering from retinal disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these Retinal Implants contribute to the market's growth. For instance, in Jan 31, 2022, Bionic Vision Technologies (BVT) announced about world-first Bionic Eye System of Australia has received breakthrough device designation from the Food and Drug Administration in the United States. This ground-breaking technology provides functional vision to people who due to Retinitis Pigmentosa (RP), the genetic condition, lost their sight.

High cost of treatment associated with retinal disorders are expected to hamper the market's growth.

However, uncertain reimbursement policies associated with these retinal implants is the key factor which may hamper the market growth. Due to the uncertainty clinicians as well as patients hesitate in adopting these devices.

The high cost of treatments associated with these retinal disorders is also a factor hindering the growth of the retinal implants market. The highly advanced implants such as Argus II cost around $115,000 to $150,000. The people living in low or middle income countries can't afford such expensive products.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The retinal implants market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials.

Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. The increasing awareness among the population regarding the ocular disorders related to retina and their treatment will also drive the market in upcoming time.

Segment Analysis

The Argus II retinal prosthesis systems segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The Argus II Retinal Prosthesis System segment is the highest market holder in the global retinal implants market. The global retinal implants market is segmented based on product type as Argus II Retinal Prosthesis System, Retina Implant Alpha IMS, Photovoltaic Retinal Implant (PRIMA), EPI-RET3, Intelligent Retinal Implant System (IRIS V2), Suprachoroidal Retinal Prosthesis, Subretinal Retinal Prosthesis. The Argus II Retinal Prosthesis Systems segment is the largest market shareholder due to the increasing adoption of these devices globally as implants, increasing technological advancements and novel product launches.

The Argus II is an epiretinal, micro-electrode array retinal prosthesis of second-generation developed and marketed by Second Sight Medical Products. It was approved for commercialization in both the United States and Europe, became the first device to receive that distinction. The design of it differs from the Argus I, the first generation model, in the spacing and number of microelectrodes on the array, the internal processing components placement (instead of subcutaneous placement in the temporal recess it is sutured onto the sclera), and the external transmission coil placement (instead of held magnetically by the internal components across the temporal bone it is built into the sidearm of the glasses).

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market's growth. For instance, in March 5, 2021, Second Sight Medical Products, a developer and seller of implantable visual prosthetics intended to develop a useful vision's artificial form for blind individuals, announced about receiving approval for the Argus 2s Retinal Prosthesis System by the U.S. Food and Drug Administration (FDA). Argus II is a redesigned external hardware (video processing unit) set initially for utilization for the treatment of retinitis pigmentosa (RP) in combination with already implanted Argus II systems.

Geographical Analysis

North America holds the largest market share in the global retinal implants market.

North America dominates the global retinal implants market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of retinal implants such as Retina Implant Alpha IMS, Photovoltaic Retinal Implant (PRIMA) and EPI-RET3, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the retinal implants market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in September 6, 2021, Bionic Vision Technologies (BVT) announced its strategic partnership with Cirtec Medical, a US MedTech company. Under this partnership, Cirtec received a strategic stake in Bionic and will further assist them in developing and producing its next-generation bionic eye.

Competitive Landscape

The retinal implants market is moderately competitive with local and global companies' presence. Bionic Vision Technologies, Vivani Medical, Inc., Samsara Vision Inc., Visus Technology Inc., Pixium Vision, Nano Retina, Labtician Ophthalmics, Inc., VisionCare, Inc., Cicor Management AG, Second Sight Medical Products Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in February 24, 2021, Diagnos Inc., a FLAIRE platform based on Artificial Intelligence (AI) developer, announced its strategic agreement of partnership with Labtician Ophthalmics, a Toronto-based company introducing and marketing DIAGNOS AI platform for ocular health monitoring and improve patient care.

Bionic Vision Technologies

Overview: Bionic Vision Technologies Pty Ltd is a medical device company based in Australia that is focused in preserving and restoring a sense of vision by creating a range of best technologies for meeting the needs of people having degenerative retinal conditions. BVT is marketing the technologies developed by Bionic Vision Australia (BVA).

Product Portfolio:

Argus II Retinal Prosthesis: It is a redesigned external hardware (video processing unit) set initially for utilization for the treatment of retinitis pigmentosa (RP) in combination with already implanted Argus II systems

The global retinal implants market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Number Of Retinal Damages
      • 4.1.1.2. Rising Geriatric Population
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost Of Treatments
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Argus II Retinal Prosthesis System*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 7.3. Retina Implant Alpha IMS
  • 7.4. Photovoltaic Retinal Implant (PRIMA)
  • 7.5. EPI-RET3
  • 7.6. Intelligent Retinal Implant System (IRIS V2)
  • 7.7. Suprachoroidal Retinal Prosthesis
  • 7.8. Subretinal Retinal Prosthesis

8. By Implants Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 8.1.2. Market Attractiveness Index, By Implants Type
  • 8.2. Epiretinal *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Subretinal
  • 8.4. Suprachoroidal

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Retinitis Pigmentosa *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Age-Related Macular Degeneration
  • 9.4. Diabetic Eye Disease
  • 9.5. Retinal Detachment

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Eye-care Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Bionic Vision Technologies *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Vivani Medical, Inc.
  • 13.3. Samsara Vision Inc.
  • 13.4. Visus Technology Inc.
  • 13.5. Pixium Vision
  • 13.6. Nano Retina
  • 13.7. Labtician Ophthalmics, Inc.
  • 13.8. VisionCare, Inc.
  • 13.9. Cicor Management AG
  • 13.10. Second Sight Medical Products Inc.

LIST NOT EXHAUSTIVE

14. Global Retinal Implants Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Medications
  • 14.3. Contact Us